Advanced pancreatic cancer: The standard of care and new opportunities

Presentation of pancreatic cancer is localized, locally advanced or metastatic. With the later represented the main bulk (more than 80%). Despite the significant innovation in molecular analysis and therapeutic approach in many types of cancer in the last two decades, still the outcome of advanced p...

Descripción completa

Detalles Bibliográficos
Autor principal: Mohammad, Amrallah A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176548/
https://www.ncbi.nlm.nih.gov/pubmed/30344961
http://dx.doi.org/10.4081/oncol.2018.370
_version_ 1783361725523820544
author Mohammad, Amrallah A.
author_facet Mohammad, Amrallah A.
author_sort Mohammad, Amrallah A.
collection PubMed
description Presentation of pancreatic cancer is localized, locally advanced or metastatic. With the later represented the main bulk (more than 80%). Despite the significant innovation in molecular analysis and therapeutic approach in many types of cancer in the last two decades, still the outcome of advanced pancreatic cancer is disappointing and the mortality rate approximately unchanged. In this mandated review we intended to highlight the standard of care and emerging agents for advanced pancreatic cancer treatment.
format Online
Article
Text
id pubmed-6176548
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-61765482018-10-19 Advanced pancreatic cancer: The standard of care and new opportunities Mohammad, Amrallah A. Oncol Rev Review Presentation of pancreatic cancer is localized, locally advanced or metastatic. With the later represented the main bulk (more than 80%). Despite the significant innovation in molecular analysis and therapeutic approach in many types of cancer in the last two decades, still the outcome of advanced pancreatic cancer is disappointing and the mortality rate approximately unchanged. In this mandated review we intended to highlight the standard of care and emerging agents for advanced pancreatic cancer treatment. PAGEPress Publications, Pavia, Italy 2018-09-14 /pmc/articles/PMC6176548/ /pubmed/30344961 http://dx.doi.org/10.4081/oncol.2018.370 Text en ©Copyright A.A. Mohammad, 2018 http://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution NonCommercial 4.0 License (CC BY-NC 4.0).
spellingShingle Review
Mohammad, Amrallah A.
Advanced pancreatic cancer: The standard of care and new opportunities
title Advanced pancreatic cancer: The standard of care and new opportunities
title_full Advanced pancreatic cancer: The standard of care and new opportunities
title_fullStr Advanced pancreatic cancer: The standard of care and new opportunities
title_full_unstemmed Advanced pancreatic cancer: The standard of care and new opportunities
title_short Advanced pancreatic cancer: The standard of care and new opportunities
title_sort advanced pancreatic cancer: the standard of care and new opportunities
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176548/
https://www.ncbi.nlm.nih.gov/pubmed/30344961
http://dx.doi.org/10.4081/oncol.2018.370
work_keys_str_mv AT mohammadamrallaha advancedpancreaticcancerthestandardofcareandnewopportunities

Ejemplares similares